Page 106 - Demo

Chapter 210472. Palat P, Hickey F, Patel L, Sannar E. Levodopa-Responsive Early-Onset Parkinsonism in Down Syndrome. Case Rep Neurol Med. 2018;2018:2314791. doi:10.1155/2018/231479173. Singer C, Sanchez-Ramos J, Weiner WJ. Levodopa-responsive parkinsonism in a patient with Down’s syndrome. Eur Neurol. 1990;30(5):247-8. doi:10.1159/00011735574. Storm W. Differential diagnosis and treatment of depressive features in Down’s syndrome: a case illustration. Res Dev Disabil. 1990;11(2):131-7. doi:10.1016/0891-4222(90)90031-375. Sturman SG, Williams AC. Parkinsonism and Down syndrome. Lancet. Oct 14 1989;2(8668):920-1. doi:10.1016/s0140-6736(89)91581-x76. Camargos S, Scholz S, Simon-Sanchez J, et al. DYT16, a novel young-onset dystoniaparkinsonism disorder: identification of a segregating mutation in the stress-response proteinPRKRA. Lancet Neurol. Mar 2008;7(3):207-15. doi:10.1016/s1474-4422(08)70022-x77. Keogh MJ, Daud D, Pyle A, et al. A novel de novo STXBP1 mutation is associated with mitochondrial complex I deficiency and late-onset juvenile-onset parkinsonism. Neurogenetics. 2014;16(1):65-67. doi:http://dx.doi.org/10.1007/s10048-014-0431-z78. Rezazadeh A, Lira V, Silberberg A, et al. Stxbp1 is associated with bruxism in awake patients. Neurology. 2019;92(15 Supplement 1)71st Annual Meeting of the American Academy of Neurology, AAN 2019. United States. 79. Yildiz EP, Yesil G, Ozkan MU, Bektas G, Caliskan M, Ozmen M. A novel EPM2A mutation in a patient with Lafora disease presenting with early parkinsonism symptoms in childhood. Seizure. Oct 2017;51:77-79. doi:10.1016/j.seizure.2017.07.01180. Hall D, Pickler L, Riley K, Tassone F, Hagerman R. Parkinsonism and cognitive decline in a fragile X mosaic male. Mov Disord. Jul 30 2010;25(10):1523-4. doi:10.1002/mds.2315081. Rosario M, Moldovan O, Reimao S, et al. Juvenile parkinsonism associated with a novel HSD17B10 mutation in a patient with HSD10 disease. Movement Disorders. 2018;33(Supplement 2):S218. 22nd International Congress of Parkinson’s Disease and Movement Disorders, MDS 2018. Hong Kong. 82. Chen JY, Oza VS, Gopi R, Christine CW. Rapidly progressive Parkinsonism in a patient with incontinentia pigmenti. Movement Disorders. 2015;30(SUPPL. 1):S476-S477. 19th International Congress of Parkinson’s Disease and Movement Disorders. San Diego, CA United States. (var.pagings). doi:http://dx.doi.org/10.1002/mds.2629583. Bach JP, Sommer N, Moller JC, Oertel WH, Dodel R, Gasser T. Parkinson’s syndrome in a young patient with Klinefelter’s syndrome--a case report. Mov Disord. Apr 15 2008;23(5):771-2. doi:10.1002/mds.2194884. Lee KS, Lee JE, Cho AH, Kim JS, Oh YS. A case of Parkinson’s disease in a patient with Klinefelter’s syndrome. Acta Neurologica Belgica. 2019;doi:http://dx.doi.org/10.1007/s13760-019-01232-185. Yu W, He Y, Liu Y. Combined Klinefelter syndrome and hereditary early-onset Parkinson’s disease: A case report. Movement Disorders Clinical Practice. 2019;6(Supplement 1):S82. 6th Asian and Oceanian Parkinson’s Disease and Movement Disorders Congress. China. doi:http://dx.doi.org/10.1002/mdc3.1274486. Fabbri M, Zibetti M, Martone T, Lopiano L. Expanding the spectrum of movement disorders in Klinefelter syndrome. Neurol Sci. Jul 2018;39(7):1303-1304. doi:10.1007/s10072-018-3296-387. Owens WE, Okun MS. Dystonia, tremor, and parkinsonism in a 54 year old man with 2-hydroxyglutaric aciduria. J Neurol Neurosurg Psychiatry. Sep 2004;75(9):1362-3. doi:10.1136/jnnp.2003.03357188. Martikainen MH, Ng YS, Gorman GS, et al. Clinical, genetic, and radiological features of extrapyramidal movement disorders in mitochondrial disease. JAMA Neurology. 2016;73(6):668-674. doi:http://dx.doi.org/10.1001/jamaneurol.2016.035589. Baumgartner A, Nia S, Erdler M, et al. A novel heteroplasmic mutation in the mitochondrial ATP6 gene associated with Parkinson’s syndrome and epilepsy. Journal of the Neurological Sciences. 2013;333(SUPPL. 1):e706. 21st World Congress of Neurology. Vienna Austria.(var.pagings). doi:http://dx.doi.org/10.1016/j.jns.2013.07.2437